|
|
|
| Diet Fuel Ephedra Free |
| by Twinlab
Clinically Proven Breakthrough Form |
|
Size :
120 Caps
SKU # :
TW0546
Prod. ID:
4716
UPC Code:
027434009454
Retail Price:
$39.00
Discount:
26%
Our Price:
$29.01
|
|
|
|
|
 |
|
|
|
|
 |
 |
|
|
 |
 |
 |
Description of Diet Fuel Ephedra Free
|
|
Twinlab’s Diet Fuel Ephedra Free is designed specifically for active females who wish to lose weight, as well as tone up and increase definition.
Diet Fuel, a patented, breakthrough Ephedra Free formula, combines an effective complex of clinically proven ingredients to increase metabolic rate, promote weight loss, and increase energy.
- Lose Weight
- Gain Energy
- New Ephedra Free
- Clinically Proven Breakthrough Formula!
|
|
 |
 |
 |
Ingredients of Diet Fuel Ephedra Free
|
|
 |
| Supplement Facts |
Serving Size: 2 Capsules |
|
| Guarana Seed Extract (22% caffeine) |
800 mg |
† |
Thermogenic Energy Enhancing Complex Citrus Aurantium Fruit Extract (standardized for 19.5 mg synephrine alkaloids) St. John's Wort Extract (aerial parts)(standardized for 0.9 mg lypericin) L-Phenylalanine Green Tea Leaf Extract (standardized for epigallotechin gallate) Quercetin Citrus Bioflavonoid Complex (containing naringin) Ginger Root Cayenne Fruit. |
685 mg |
† |
|
| Other Ingredients: Gelatin, Purified Water, MCT, Silica, Magnesium Stearate. |
†: Daily value not established.
|
|
|
|
 |
 |
 |
Suggested Use for Diet Fuel Ephedra Free
|
|
|
As a dietary supplement take two (2) capsules before each meal. Do not exceed six (6) capsules daily. Taking more than the recommended amount will not improve results and may cause adverse reactions listed in the warning below.
|
|
 |
 |
 |
Warning for Diet Fuel Ephedra Free
|
|
|
Not for use by individuals under the age of 18. Do not use if you are pregnant or nursing or if you are at risk or are being treated for heart, liver, thyroid, or psychiatric disease, diabetes, pernicious anemia, nervousness, anxiety, depression, seizure disorder, stroke or difficulty in urination due to prostate enlargement.
|
|
 |
 |
 |
|
|
 |
 |
 |
|
|
|
|